Medicare Enrolled

Dr. Kruti Dajee, M.D.

Ophthalmology · McKinney, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2745 VIRGINIA PKWY STE 300, McKinney, TX 75071
4693434231
In practice since 2011 (14 years)
NPI: 1043506215 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dajee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dajee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dajee

Dr. Kruti Dajee is an ophthalmology in McKinney, TX, with 14 years in practice. Based on federal Medicare data, Dr. Dajee performed 15,953 Medicare services across 2,694 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dajee received a total of $921 from 11 pharmaceutical and/or device companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dajee is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 7% volume in TX$ $921 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,953
Medicare services
Top 7% in TX for ophthalmology
2,694
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,140 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)7,620$29$73
Retinal imaging (OCT scan)2,456$29$84
Comprehensive eye exam, established patient1,712$89$260
Aflibercept eye injection (Eylea)1,286$686$1,927
Eye injection for retinal disease1,266$93$207
Injection, bevacizumab, 10 mg695$54$159
Extended exam of the back part of the eye with retinal drawing273$17$50
Injection, dexamethasone, intravitreal implant, 0.1 mg203$147$399
New patient office visit (45-59 min)153$108$335
Comprehensive eye exam, new patient136$97$310
Destruction of leaking blood vessels of retina using laser33$244$950
New patient office visit, complex (60-74 min)23$139$423
Photocoagulation treatment to prevent detachment of retina21$170$1,087
Removal of membrane of retina with removal of internal limiting membrane of retina19$861$2,361
Office visit, established patient (30-39 min)19$85$222
Repair of detached retina with drainage and removal of eye fluid between lens and retina13$912$2,458
2d ultrasound scan of eye tissue and structures13$37$109
Eye exam, established patient, focused12$68$182
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$921
Total received (2018-2024)
Avg $154/year across 6 years
Bottom 36% in TX for ophthalmology
11
Companies
28
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$921 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$290
2023
$236
2022
$134
2021
$21
2019
$45
2018
$196

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Laboratories Inc
$150
ABBVIE INC.
$145
Genentech USA, Inc.
$131
Apellis Pharmaceuticals, Inc.
$123
Alcon Vision LLC
$120
AbbVie Inc.
$67
Astellas Pharma US Inc
$49
Novartis Pharmaceuticals Corporation
$46
Alimera Sciences, Inc.
$45
Harrow Eye, LLC
$30
Regeneron Healthcare Solutions, Inc.
$15
Top 3 companies account for 46.2% of total payments
Associated products mentioned in payments ›
ACTIVEFOCUS · BROLUCIZUMAB · Clareon · EYLEA · IHEEZO · Iluvien · Izervay · Lucentis · OZURDEX · Syfovre · Vabysmo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $6 per 100 Medicare services performed
Looking for a ophthalmology in McKinney?
Compare ophthalmologys in the McKinney area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
74
Per 100K population
6.6
County median income
$117,588
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER MCKINNEY
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dajee is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dajee experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Dajee performed 7,620 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dajee receive payments from pharmaceutical companies?
Yes. Dr. Dajee received a total of $921 from 11 companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dajee's costs compare to other ophthalmologys in McKinney?
Dr. Dajee's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dajee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →